The Securities & Markets team at MFSA recently got together to raise funds for ALIVE Charity Foundation, in their quest to fight cancer by funding research.
MFSA COO Reuben Fenech presented a donation to Michael Gafa from Alive Foundation & Dr Duncan Ayers, researcher at University of Malta (Centre for Molecular Medicine and Biobanking) to support their invaluable work for increasing cancer chemotherapy effectiveness using microRNA technology.
This research, led by Dr Ayers, will hopefully lead to a new combination drug that will render conventional cancer chemo cycles much more potent.'
This research, led by Dr Ayers, will hopefully lead to a new combination drug that will render conventional cancer chemo cycles much more potent.'